Tom Shea

Chief Financial Officer
Pharmaceutical Sciences
Albireo Pharma
Sweden

Business Expert Pharmaceutical Sciences
Biography

Tom Shea joined Albireo in July 2016 as Chief Financial Officer. Previously, he served as Executive Vice President and Chief Financial Officer of Epirus Biopharmaceuticals, a multinational biosimilar company. Prior to Epirus, Tom served as the Chief Financial Officer of multiple biopharmaceutical companies, including Tolerx and sister companies Euthymics, Neurovance, and EBI Life Sciences. Formerly, he was Chief Financial Officer at Cubist Pharmaceuticals (acquired by Merck) where he was one of its initial employees and served for 10 years, playing a leadership role in Cubist’s successful initial public offering

Research Intrest

Biopharmaceuticals, Pharmacy

Global Scientific Words in Pharmaceutical Sciences